Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): Study protocol for a randomized controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Gouëffic, Yann ^a,b,c   Kaladji, Adrien ^a   Guyomarch, Béatrice ^a   Montagne, Carine ^a   Fairier, Damien ^a   Gestin, Simon ^d   Riche, Valéry Pierre ^a   Vent, Pierre Alexandre ^a   Chaillou, Philippe ^a   Costargent, Alain ^a   Patra, Philippe ^a,c  

^a L INSTITUT DU THORAX   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Bare metal stent; Drug eluting stent; Paclitaxel; Superficial femoral artery

Indexed keywords

ACETYLSALICYLIC ACID; PACLITAXEL; THIENOPYRIDINE DERIVATIVE; CARDIOVASCULAR AGENT; METAL;

ARTERY LESION; ARTICLE; BARE METAL STENT; CLINICAL PROTOCOL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; FEMOROPOPLITEAL ARTERIAL LESION; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PEAK SYSTOLIC VELOCITY; PROCESS DESIGN; PROSPECTIVE STUDY; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TREATMENT RESPONSE; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICES; FEMORAL ARTERY; FRANCE; METHODOLOGY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSTHESIS; RECURRENT DISEASE; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; SWITZERLAND; TIME; TREATMENT OUTCOME;

CARDIOVASCULAR AGENTS; CLINICAL PROTOCOLS; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; FEMORAL ARTERY; FRANCE; HUMANS; METALS; PACLITAXEL; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; RESEARCH DESIGN; STENTS; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 84920825229     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-423     Document Type: Article

References (14)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG: Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007,45(Suppl S):S5-S67.
2. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, Koppensteiner R, Minar E, Schillinger M: Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009,74(7):1090-1095. 10.1002/ccd.22128.
3. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR, Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR: Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010,3(3):267-276. 10.1161/CIRCINTERVENTIONS.109.903468.
4. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E: Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006,354(18):1879-1888. 10.1056/NEJMoa051303.
5. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002,346(23):1773-1780. 10.1056/NEJMoa012843.
6. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP: Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006,13(6):701-710. 10.1583/05-1704.1.
7. Lammer J, Bosiers M, Zeller T, Schillinger M, Boone E, Zaugg MJ, Verta P, Peng L, Gao X, Schwartz LB: First clinical trial of nitinol self-expanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg 2011,54(2):394-401. 10.1016/j.jvs.2011.01.047.
8. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS: Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011,4(5):495-504. 10.1161/CIRCINTERVENTIONS.111.962324.
9. Schulte KL, Kralj I, Gissler HM, Bagnaschino LA, Buschmann I, Pernes JM, Haage P, Goverde P, Beregi JP, Valka M, Boudny J, Geibel T, Velkoborsky M, Zahringer M, Paetzel C, Fanelli F, Muller-Hulsbeck S, Zeller T, Langhoff R: MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients. J Endovasc Ther 2012,19(6):774-784. 10.1583/JEVT-12-3861MR.1.
10. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG: CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c869. 10.1136/bmj.c869.
11. Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Trials 2010, 11:32. 10.1186/1745-6215-11-32.
12. Ranke C, Creutzig A, Alexander K: Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 1992,18(5):433-440. 10.1016/0301-5629(92)90082-L.
13. Eiberg JP, Madycki G, Hansen MA, Christiansen S, Gronvall Rasmussen JB, Schroeder TV: Ultrasound imaging of infrainguinal arterial disease has a high interobserver agreement. Eur J Vasc Endovasc Surg 2002,24(4):293-299. 10.1053/ejvs.2002.1724.
14. Wain RA, Berdejo GL, Delvalle WN, Lyon RT, Sanchez LA, Suggs WD, Ohki T, Lipsitz E, Veith FJ: Can duplex scan arterial mapping replace contrast arteriography as the test of choice before infrainguinal revascularization? J Vasc Surg 1999,29(1):100-107. Discussion 107-9 10.1016/S0741-5214(99)70352-6.